Peter F. Incze

University Health Network Mount Sinai Hospital Women's College Hospital, 585 University Ave, 1PMB-292
Toronto, ON M5G2N2, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial.

External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial.

Journal: The Journal of urology
Published: April 28, 2026

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.

Journal: JAMA
Published: March 23, 2025

MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.

MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.

Journal: Radiology
Published: March 05, 2024

Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.

Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.

Journal: Radiology
Published: July 19, 2022

MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.

MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.

Journal: Radiology
Published: April 26, 2021

MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.

MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.

Journal: Radiology
Published: February 02, 2021

Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients.

Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients.

Journal: European urology focus
Published: December 04, 2020

Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.

Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.

Journal: The Canadian journal of urology
Published: June 26, 2017

Three year results of the prostatic urethral L.I.F.T. study.

Three year results of the prostatic urethral L.I.F.T. study.

Journal: The Canadian journal of urology
Published: June 13, 2015

Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study.

Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study.

Journal: Urology practice
Published: January 01, 2015

The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.

The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.

Journal: The Journal of urology
Published: May 30, 2013

UroLift system for relief of prostate obstruction under local anesthesia.

UroLift system for relief of prostate obstruction under local anesthesia.

Journal: The Canadian journal of urology
Published: April 20, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026